Intrinsic Pathway for Apoptosis

Pathway network for the Intrinsic Pathway for Apoptosis SuperPath

Sources:
  • Reactome

Pathways in the Intrinsic Pathway for Apoptosis SuperPath

#NameSourceGenes
1Intrinsic Pathway for ApoptosisReactome
2Activation of BH3-only proteinsReactome
3Activation of BAD and translocation to mitochondriaReactome
4Apoptotic factor-mediated responseReactome
5BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 membersReactome
6Activation of PUMA and translocation to mitochondriaReactome
7Activation of NOXA and translocation to mitochondriaReactome
8Activation of BIM and translocation to mitochondriaReactome
9Release of apoptotic factors from the mitochondriaReactome
10Activation of BMF and translocation to mitochondriaReactome
11Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of FunctionReactome
12SMAC, XIAP-regulated apoptotic responseReactome

Gene overlap in member pathways for Intrinsic Pathway for Apoptosis SuperPath

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with Intrinsic Pathway for Apoptosis SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Breast adenocarcinomaEnrichmentAKT1, TP534.31
2Li-fraumeni syndromeEnrichmentCDKN2A, TP533.97
3Adrenocortical carcinomaEnrichmentCDKN2A, TP533.97
4Combined oxidative phosphorylation deficiency 33EnrichmentC1QBP3.83
5Cdkn2a cancer predispositionEnrichmentCDKN2A3.83
6Spermatogenic failure 99EnrichmentSEPTIN43.83
7B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)EnrichmentCDKN2A, TP533.82
8Deafness, autosomal dominant 5EnrichmentGSDME3.66
9Adult hepatocellular carcinomaEnrichmentCASP8, TP533.59
10Melanoma-astrocytoma syndromeEnrichmentCDKN2A3.53
11Melanoma, cutaneous malignant 2EnrichmentCDKN2A3.53
12Melanoma-pancreatic cancer syndromeEnrichmentCDKN2A3.53
13Bone marrow failure syndrome 5EnrichmentTP533.43
14Papilloma of choroid plexusEnrichmentTP533.43
15Basal cell carcinoma 7EnrichmentTP533.43
16Anaplastic thyroid carcinomaEnrichmentTP533.43
17Ductal carcinoma in situEnrichmentTP533.43
18Thyroid gland undifferentiated carcinomaEnrichmentTP533.43
19Small-cell carcinoma of the ovary of hypercalcemic typeEnrichmentTP533.43
20Diffuse pediatric-type high-grade glioma, h3-wildtype and idh-wildtypeEnrichmentTP533.43
21Choroid plexus cancerEnrichmentTP533.43
22Pleomorphic xanthoastrocytomaEnrichmentTP533.43
23Specific learning disabilityEnrichmentMAPK1, YWHAG3.41
24Lip and oral cavity carcinomaEnrichmentCDKN2A, TP533.33
25T-cell large granular lymphocyte leukemiaEnrichmentSTAT33.23
26Autoimmune disease, multisystem, infantile-onset, 1EnrichmentSTAT33.23
27Stat3-related early-onset multisystem autoimmune diseaseEnrichmentSTAT33.23
28Chronic lymphoproliferative disorder of natural killer cellsEnrichmentSTAT33.23
29Noonan syndrome 13EnrichmentMAPK13.18
30Adrenocortical carcinoma, hereditaryEnrichmentTP533.13
31Cervical cancerEnrichmentTP533.13
32Lymphoma, hodgkin, classicEnrichmentTP533.13
33Congenital fibrosarcomaEnrichmentTP533.13
34Li-fraumeni syndrome 1EnrichmentTP533.13
35SarcomaEnrichmentTP533.13
36Cervix carcinomaEnrichmentTP533.13
37Hodgkin's lymphomaEnrichmentTP533.13
38Pleomorphic rhabdomyosarcomaEnrichmentTP533.13
39Lung squamous cell carcinomaEnrichmentCDKN2A3.05
40Proteus syndromeEnrichmentAKT12.99
41Hypoinsulinemic hypoglycemia with hemihypertrophyEnrichmentAKT22.99
42Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2EnrichmentAKT32.99
43Cowden syndrome 6EnrichmentAKT12.99
44Developmental and epileptic encephalopathy 56EnrichmentYWHAG2.99
45Capillary hemangiomaEnrichmentAKT32.99
46Distal 17p13.3 microdeletion syndromeEnrichmentYWHAE2.99
47Akt2-related familial partial lipodystrophyEnrichmentAKT22.99
48Breast cancerEnrichmentAKT1, CASP8, TP532.96
49Osteogenic sarcomaEnrichmentTP532.96
50Nasopharyngeal carcinomaEnrichmentTP532.96
51Atypical teratoid rhabdoid tumorEnrichmentTP532.96
52Anaplastic astrocytomaEnrichmentTP532.96
53Squamous cell carcinomaEnrichmentTP532.96
54AdenocarcinomaEnrichmentTP532.96
55Bone osteosarcomaEnrichmentTP532.96
56Intravascular large b-cell lymphomaEnrichmentBCL22.93
57Male infertility due to globozoospermiaEnrichmentSEPTIN42.93
58Diffuse large b-cell lymphomaEnrichmentSTAT3, TP532.92
59Small cell cancer of the lungEnrichmentTP532.83
60Thyroid cancer, nonmedullary, 1EnrichmentTP532.83
61Lung sarcomatoid carcinomaEnrichmentTP532.83
62Embryonal rhabdomyosarcomaEnrichmentTP532.83
63MelanomaEnrichmentCDKN2A2.83
64Hepatocellular carcinomaEnrichmentCASP8, TP532.79
65Leukemia, acute lymphoblasticEnrichmentCDKN2A2.79
66Hyper-ige syndrome 1, autosomal dominant, with recurrent infectionsEnrichmentSTAT32.75
67Breast implant-associated anaplastic large cell lymphomaEnrichmentSTAT32.75
68Hyper ige syndromeEnrichmentSTAT32.75
69High-grade b-cell lymphoma double-hit/triple-hitEnrichmentBCL22.75
70Rhabdomyosarcoma 2EnrichmentTP532.73
71LymphomaEnrichmentTP532.73
72Acute megakaryocytic leukemiaEnrichmentTP532.73
73Senior-loken syndrome 7EnrichmentAKT32.69
74Bardet-biedl syndrome 16EnrichmentAKT32.69
75Pancreatic cancerEnrichmentCDKN2A, TP532.68
76Melanoma, cutaneous malignant 1EnrichmentCDKN2A2.60
77Esophageal cancerEnrichmentTP532.59
78Squamous cell carcinoma, head and neckEnrichmentTP532.59
79Essential thrombocythemiaEnrichmentTP532.59
80Gallbladder cancerEnrichmentTP532.59
81Ovarian cancerEnrichmentAKT1, CDKN2A, TP532.59
82Chromosome 22q11.2 deletion syndrome, distalEnrichmentMAPK12.58
83Caspase 8 deficiencyEnrichmentCASP82.56
84Bladder cancerEnrichmentCDKN2A, TP532.55
85Hereditary breast carcinomaEnrichmentAKT1, TP532.53
86Follicular lymphomaEnrichmentBCL22.53
87Glioma susceptibility 1EnrichmentTP532.53
88Lymphoma, non-hodgkin, familialEnrichmentTP532.53
89Miller-dieker lissencephaly syndromeEnrichmentYWHAE2.51
90Chromosome 17p13.3, centromeric, duplication syndromeEnrichmentYWHAE2.51
91Primary hyperaldosteronismEnrichmentTP532.48
92Precursor t-cell acute lymphoblastic leukemiaEnrichmentCDKN2A2.47
93Leukemia, chronic lymphocyticEnrichmentTP532.43
94Familial colorectal cancerEnrichmentTP532.43
95Myelodysplastic syndromeEnrichmentTP532.39
96Megalencephaly-capillary malformation-polymicrogyria syndromeEnrichmentAKT32.38
97Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1EnrichmentAKT32.38
98Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemiaEnrichmentYWHAZ2.38
99Permanent neonatal diabetes mellitusEnrichmentSTAT32.33
100HemimegalencephalyEnrichmentAKT32.29
101Endometrial stromal sarcomaEnrichmentYWHAE2.29
102Lung cancer susceptibility 3EnrichmentTP532.29
103RhabdomyosarcomaEnrichmentTP532.23
104GliosarcomaEnrichmentTP532.23
105Gastric cancerEnrichmentCDKN2A, TP532.22
106Kidney clear cell sarcomaEnrichmentYWHAE2.21
107Giant cell glioblastomaEnrichmentTP532.20
108MegacolonEnrichmentAKT32.14
109Acute promyelocytic leukemiaEnrichmentSTAT32.12
110HepatoblastomaEnrichmentTP532.11
111Diamond-blackfan anemia 1EnrichmentTP532.07
112Cowden syndromeEnrichmentAKT12.03
113PolymicrogyriaEnrichmentAKT31.99
114Prostate cancerEnrichmentTP531.97
115Colorectal cancerEnrichmentAKT1, TP531.96
116Rare autosomal dominant non-syndromic sensorineural deafness type dfnaEnrichmentGSDME1.94
117Heart, malformation ofEnrichmentMAPK11.93
118MeningiomaEnrichmentAKT11.91
119Mitochondrial diseaseEnrichmentC1QBP1.89
120Diamond-blackfan anemiaEnrichmentTP531.88
121Leukemia, acute myeloidEnrichmentTP531.83
122Rare genetic deafnessEnrichmentGSDME1.76
123Inherited cancer-predisposing syndromeEnrichmentCDKN2A1.71
124Hereditary breast ovarian cancer syndromeEnrichmentTP531.70
125Myeloma, multipleEnrichmentTP531.69
126Type 2 diabetes mellitusEnrichmentAKT21.37
127MicrocephalyEnrichmentMAPK1, YWHAG1.35
128Autosomal dominant non-syndromic intellectual disabilityEnrichmentYWHAZ1.30
129Undetermined early-onset epileptic encephalopathyEnrichmentYWHAG1.25
130Lung cancerEnrichmentCASP81.08

Loading...
Loading...
Loading...